Bacteriophages: A Revisited Strategy for the Treatment of Severe Bacterial Infections
Author(s) -
R.J.S. Badaró
Publication year - 2020
Publication title -
journal of bioengineering technologies and health
Language(s) - English
Resource type - Journals
eISSN - 2674-8568
pISSN - 2595-2137
DOI - 10.34178/jbth.v2i3.74
Subject(s) - phage therapy , microbiology and biotechnology , antibiotics , bacteria , virulence , antibiotic resistance , pathogen , biology , bacteriophage , virology , gene , escherichia coli , genetics
Bacteriophages are viruses that infect and parasitize bacteria. The current increase in the incidence of antibiotic resistance in human bacteria has favoredthe study of phages as a therapeutic alternative (phage therapy). Phage therapy is defined as the administration of virulent phages directly to a patient to lyse the bacterial pathogen that is causing a clinically severe infection. The ideal route of administration and modification of bacteriopaghes genetically to deactivate bacterial resistance genes is the next future to antibiotic recovery sensitivity of MDR organisms.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom